During the past decade, Vithas Hospital Sevilla conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vithas Hospital Sevilla" are "Multiple Sclerosis" (2 trials), "Type 2 Diabetes" (2 trials), "Obesity" (1 trials), "Overweight" (1 trials) and "Spasticity With Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Vithas Hospital Sevilla" in a lesser frequency.

Most popular intervention types in "Vithas Hospital Sevilla" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Insulin Efsitora Alfa" (2 trials), "Placebo" (2 trials), "Insulin Degludec" (1 trials), "Insulin Glargine (U100)" (1 trials) and "Insulin Lispro (U100)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vithas Hospital Sevilla" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Vithas Hospital Sevilla". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Vithas Hospital Sevilla, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Vithas Hospital Sevilla, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".